{
    "Trade/Device Name(s)": [
        "cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test",
        "cobas\u00ae liat SARS-CoV-2, Influenza A/B & RSV"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K243406",
    "Predicate Device Reference 510(k) Number(s)": [
        "K241240"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "October 31, 2024",
    "Summary Letter Received Date": "November 1, 2024",
    "Submission Date": "April 2, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "POCT"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 RNA",
        "Influenza A RNA",
        "Influenza B RNA",
        "RSV RNA"
    ],
    "Specimen Type(s)": [
        "Anterior Nasal Swab",
        "Nasopharyngeal Swab"
    ],
    "Specimen Container(s)": [
        "Copan FLOQSwabs\u2122 with UTM\u2122",
        "BD UVT with flocked swab",
        "Sterile flocked swabs with synthetic tip with other viral transport media (VTM)",
        "Remel\u2122 MM4RT",
        "Remel\u2122 M4",
        "Remel\u2122 M5",
        "Remel\u2122 M6",
        "0.9% Saline"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae liat System",
        "cobas\u00ae liat analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex real-time reverse transcription polymerase chain reaction (RT-PCR)",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Qualitative molecular detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for cobas liat SARS-CoV-2, Influenza A/B & RSV multiplex rapid RT-PCR assay on cobas\u00ae liat System for qualitative detection of SARS-CoV-2, Influenza A/B, and RSV in respiratory swabs",
    "Indications for Use Summary": "Automated rapid multiplex RT-PCR assay for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, influenza B virus, and RSV nucleic acids in anterior nasal and nasopharyngeal swabs from symptomatic individuals, aiding differential diagnosis of respiratory viral infections",
    "fda_folder": "Microbiology"
}